Home > Healthcare & Medical Devices > Health Economics & Outcomes Research (HEOR) Services Market

Health Economics & Outcomes Research (HEOR) Services Market Size By Service (Economic Modeling/Evaluation, Real-world Data Analysis & Information Systems, Clinical Outcome, Market Access Solutions & Reimbursement), By Service Provider (Consultancy, Contract Research Organizations), By End-use (Healthcare Providers, Healthcare Payers, Biotech/Pharma Companies, Government Organizations), COVID-19 Impact Analysis, Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2023 – 2032

  • Report ID: GMI3145
  • Published Date: Dec 2022
  • Report Format: PDF

Industry Statistics

Health Economics & Outcomes Research Services Market size was valued at over USD 1 billion in 2022. The industry is estimated to grow at more than 14% CAGR from 2023 to 2032 driven by growing healthcare concerns in the post-pandemic.
 

Health Economics & Outcomes Research Services Market

Get more details on this report - Request Free Sample PDF
 

One of the primary factors driving the expansion of the health economics and outcomes research services industry is the increasing focus of pharmaceutical and biotechnology companies on the development of novel drugs for the treatment of different chronic conditions. For instance, the Center for Drug Evaluation and Research (CDER) approved 50 new drugs in 2021. Additionally, the number of businesses gaining drug approvals has increased over time, which has been advantageous for the expansion of the overall industry.
 

The strong growth of clinical trials is also contributing to the HEOR services market growth. Health economics and outcomes research supplement clinical drug trials by giving crucial information and research data, assisting decision-makers and healthcare payers in determining patient access to specific medication trials. The success rate of new drugs in some European nations, such as the Netherlands, the UK, and others is very high. Infact, each year, approximately 4,000 clinical trials are approved in Europe.
 

Shortage of skilled professionals may restrain industry progression

Lack of skilled healthcare professionals in developing and underdeveloped economies is impeding the HEOR services market demand. There is a constant need for highly skilled personnel to handle and analyze developed and technically advanced data, particularly in the data collection and analysis sector. Unfortunately, the market for health economics and outcomes research (HEOR) services has consistently struggled to find qualified workers because of the low availability of advanced HEOR services. Nonetheless, developments in HEOR services are likely to aid in combatting the issue.
 

Increasing number of new drugs to help market access solutions & reimbursement segment gain traction

In terms of service, the HEOR services market is categorized into market access solutions & reimbursement, economic modeling/evaluation, clinical outcome, real-world data analysis & information systems, and others. The market access solutions & reimbursement segment is speculated to witness growth at more than 14.5% CAGR from 2023-2032. The segment includes tools and services for evidence generation and safeguard patient access to drugs at reasonable prices. The burgeoning drug launches and therapies are also accelerating the demand for market access solutions and reimbursement services.
 

Soaring need for decision making and business solutions to accelerate the demand for consultancies

Global Health Economics & Outcomes Research Services Market Share, By Service Provider

Get more details on this report - Request Free Sample PDF
 

With respect to the service provider, the health economics & outcomes research (HEOR) services market is divided into consultancy and contract research organizations (CRO). The consultancy segment is anticipated to depict a growth of over 14.5% between 2023 and 2032. The consultants assist businesses with advice and ideas regarding prudent regulatory requirements. Additionally, the preference for consulting services that support decision-making and provide appropriate business solutions is poised to create several prospects for business expansion.
 

Cumulative consumer-driven healthcare demand to popularize HEOR services among healthcare payers

Global Health Economics & Outcomes Research Services Market Size, By End-use

Get more details on this report - Request Free Sample PDF
 

In terms of end-use, the HEOR services market is segmented into healthcare providers, biotech/pharma companies, healthcare payers, government organizations, and others. The global market size from the healthcare payers is foreseen to reach USD 1.2 billion in revenue by 2032. This growth is attributed to increasing reliance of healthcare payers on HEOR studies owing to the transition from fee-for-service to value-based reimbursement, increased consumer-driven healthcare, and rising usage of specialty medications & targeted therapies, healthcare payers are pushing healthcare payers to adopt HEOR studies. The development of analytical tools in healthcare IT enables system alignment across several platforms, further impacting the market positively.
 

Significant expenditure on R&D studies to aid increase product rate in Asia Pacific

Global Health Economics & OutComes Research Services Market Share, By region, 2022 (USD Mn)

Get more details on this report - Request Free Sample PDF
 

Regionally, the global HEOR services market is segregated into Europe, Asia Pacific, North America, the Middle East & Africa, and Latin America. Asia Pacific industry is slated to expand at more than 15.5% CAGR over 2023-2032. The region is set to experience rapid growth driven by high R&D funding by regional pharma giants. Additionally, the region's huge population base and favorable regulatory environment contribute to the market's expansion for HEOR services.
 

Favorable partnerships with pharmaceutical companies to strengthen the health economics & outcomes research (HEOR) services industry outlook

McKesson Corporation, Axtria, Cardinal Health, Avalon Health Economics, MEDLIOR, IQVIA, PharmaLex GmbH, Syneos Health, RTI Health Solutions, ICON plc, PPD Inc. (Thermo Fisher Scientific, Inc.), and Optum, Inc. are some of the key HEOR services market players. These companies majorly engage in growth collaborations and alliances to expand their customer base. For instance, in September 2021, Pharmaceutical company IQVIA worked strategically with HealthCore Inc, a clinical research institution in the United States. The partnership improved the impact of real-world studies and unique research designs.
 

Impact of COVID-19 on the HEOR services market trends

Due to several restrictions on healthcare services and workforce shortage, the pandemic had a moderate impact on the HEOR services industry. The rising prevalence of COVID-19 cases had a significant impact on the healthcare sector. HEOR professionals were closely involved in pandemic-related healthcare issues, examining concerns such as disease incidence and health consequences, disease economic impacts, and treatment options such as vaccines and therapies. All through early 2020, the unexpected consequence of pandemic disrupted the HEOR services industry. However, the greater use of real-world evidence following the COVID-19 outbreak is driving the demand for health economics & outcomes research services.
 

The HEOR service market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments:

By Service

  • Economic Modelling/ Evaluation
  • Real-World Data Analysis and Information Systems
  • Clinical Outcome
  • Market Access Solutions and Reimbursement
  • Others

By Service Provider

  • Consultancy
  • Contract Research Organizations (CROs)

By End-use

  • Healthcare Providers
  • Healthcare Payers
  • Biotech/Pharma Companies
  • Government Organizations
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
  • Asia Pacific
    • China
    • India
    • Japan
  • Latin America
    • Brazil
    • Mexico
  • Middle East and Africa
    • South Africa
    • Saudi Arabia

 

Authors: Sumant Ugalmugle, Rupali Swain

Frequently Asked Questions (FAQ) :

Global HEOR Services market revenue was crossed USD 1 billion in 2021 and is set to progress at more than 14% CAGR through 2032 owing to increasing focus of pharmaceutical and biotechnology companies on the development of novel drugs for the treatment of various chronic conditions.

The overall market revenue from healthcare payers is anticipated to reach USD 1.2 billion in revenue by the end of 2032 due to benefits such as increased consumer-driven healthcare, and rising usage of specialty medications & targeted therapies.

The consultancy segment is poised to depict the growth of over 14.5% between 2023 and 2032 driven by increasing preference for consulting services that support decision-making and provide appropriate business solutions.

The Asia Pacific health economics & outcomes research services market is slated to expand at more than 15.5% CAGR over 2023-2032 on account of the huge population base and favorable regulatory environment in the region.

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

  • Base Year: 2022
  • Companies covered: 12
  • Tables & Figures: 171
  • Countries covered: 14
  • Pages: 151

Get a report that explains COVID-19 impact on this market

 Request Free Sample

Budget constraints? Get in touch with us for special pricing

Request Discount